comparemela.com

Latest Breaking News On - Christopher bunick - Page 3 : comparemela.com

Utilizing JAK Inhibitors in Clinical Practice

Dermatology experts discuss the use of JAK inhibitors in clinical practice, highlighting their own experiences and use of JAKs alongside corticosteroids.

Christopher bunickAlexandra golantLisa swansonPeter lioJak inhibitorsInadequate responseSuppressed diseaseStandard of care

Clinical Pearls for the Treatment of AD

Expert dermatologists share clinical pearls for providers treating patients with AD, and discuss the future of AD treatment.

Alexandra golantLisa swansonChristopher bunickPeter lioAtopic dermatitisDisease controlSystemic therapyQuality of lifeHitch freeFuture considerations

Contraindications for Use of JAK Inhibitors in AD

Peter Lio, MD, reviews the contraindications of JAK inhibitors in AD and approaches for monitoring patients who are prescribed a JAK inhibitor.

Christopher bunickLisa swansonAlexandra golantPeter lioJak inhibitorsAtopic dermatitis

Treatment Selection of JAK Inhibitors for the Management of AD

Expert dermatologists speak on shared-decision making between the patient and the provider when it comes to selecting the right therapy for AD.

Christopher bunickLisa swansonAlexandra golantPeter lioJak inhibitorsSuppressed diseaseStandard of care

Safety of JAK Inhibitors Approved for AD Treatment

Expert dermatologists review the safety data of the current JAK inhibitors approved for AD, highlighting adverse events and long-term safety data.

Christopher bunickAlexandra golantLisa swansonPeter lioJak inhibitorsAtopic dermatitisSafety profileSide effectsLab monitoringLong term safetyBoxed warning

vimarsana © 2020. All Rights Reserved.